cigna glp 1 2025 requirements Cigna's Evernorth launches Wegovy, Zepbound copayment cap Does Cigna cover Zepbound?
Description
10.3892/or.2020.7595 186 ZhangR.LiangQ.KangW.GeS
However, high discontinuation rates, driven primarily by gastrointestinal adverse events, posed a significant barrier to achieving these outcomes
The weight-loss effects and side effects of glucagon-like peptide-1 (GLP-1) receptor agonists, widely used as obesity treatments like Wegovy, vary from person to person
[DOI] [PubMed] [Google Scholar] 15.Ko JW, Park KD, Lee Y, Lee JH, Hong DK
